• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SINUSAFE MEDICAL LTD SINUSAFE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SINUSAFE MEDICAL LTD SINUSAFE Back to Search Results
Catalog Number SNS-1001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Swelling/ Edema (4577)
Event Date 10/22/2020
Event Type  Injury  
Manufacturer Narrative
The physician assumed that the periorbital swelling is related to the patient's facial trauma history, which allowed the drug application pressure to escape the sinus cavity.The device was inspected by the company's representative after the procedure, and was found intact.No malfunction was detected.Per clinical opinion of this occurrence, it seems that the periorbital swelling that occurred after drug application is linked to the patient's facial trauma history that allowed the drug application pressure to escape the sinus cavity into the eyelid.The combination of the drug's jelly-like state which required higher pressure during application and the unique physiological structure of the patient, following facial trauma, apparently led to the occurrence.Based on this information, device inspection and occurrence circumstances, it is not likely that the occurrence is device related.
 
Event Description
After maxillary sinus irrigation with a sinusafe device, and after compounded drug application into the sinus, the physician noted periorbital swelling.During application, the drug was not in a liquid state but in a jelly-like state.The treatment was performed under general anesthesia.The compound applied was cpd lev/bud 100mg-0.5mg/10mg, lot number: 4476510, compounded by (b)(6).Upon noticing the periorbital swelling by the user (ent physician), the patient was treated with lamina papyracea puncturing to relieve eye pressure and sent for ophthalmology examination.The ophthalmology examination included a physician check-up and ct scan.The physician reported to the company's representative that the examination verified no orbital damage and no vision damage.He also reported that the ct scan showed that the drug was positioned correctly in the bottom of the maxillary sinus cavity confirming that the drug was administered into the sinus cavity as intended and did not penetrate into the eye cavity.The patient did not require hospitalization.She reported to the physician a history of facial trauma.According to the physician report to the company's representative, the swelling was noted to improve since the procedure as of (b)(6) 2020.No additional intervention was performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SINUSAFE
Type of Device
SINUSAFE
Manufacturer (Section D)
SINUSAFE MEDICAL LTD
6 yoni netanyahu st.
or yehuda, tel-aviv 60376 04
IS  6037604
Manufacturer (Section G)
TARYAG STERILIZATION LTD
po box 148
14 ha'ilan st.
or akiva, 30651 01
IS   3065101
Manufacturer Contact
avinoam gemer
6 yoni netanyahu st.
or yehuda, tel-aviv 60376-04
IS   6037604
MDR Report Key10999172
MDR Text Key221238653
Report Number3014269548-2020-00001
Device Sequence Number1
Product Code LRD
Combination Product (y/n)N
Reporter Country CodeIS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Administrator/Supervisor
Remedial Action Relabeling
Type of Report Initial
Report Date 11/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/21/2021
Device Catalogue NumberSNS-1001
Device Lot NumberSINU20005
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/22/2020
Initial Date Manufacturer Received 10/22/2020
Initial Date FDA Received12/13/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/22/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age40 YR
Patient Weight60
-
-